| Pharmaceutical Information |
| Drug Name |
Sargramostim |
| Drug ID |
BADD_D01990 |
| Description |
Sargramostim is a human recombinant granulocyte macrophage colony-stimulating factor (GM-CSF) expressed in yeast. It is a glycoprotein that is 127 residues. Substitution of Leu23 leads to a difference from native protein. |
| Indications and Usage |
For the treatment of cancer and bone marrow transplant |
| Marketing Status |
Prescription |
| ATC Code |
L03AA09 |
| DrugBank ID |
DB00020
|
| KEGG ID |
D05803
|
| MeSH ID |
C081222
|
| PubChem ID |
Not Available
|
| TTD Drug ID |
D0XT5Y
|
| NDC Product Code |
71837-5843 |
| Synonyms |
sargramostim | 23-L-leucine-colony-stimulating factor 2 (human clone pHG25 protein moiety) | Leukine | Prokine |
|
| Chemical Information |
| Molecular Formula |
Not Available |
| CAS Registry Number |
123774-72-1 |
| SMILES |
Not Available |
| Chemical Structure |
|
|
| ADR Related Proteins Induced by Drug |
| ADR Term |
Protein Name |
UniProt AC |
TTD Target ID |
PMID |
| Not Available | Not Available | Not Available | Not Available | Not Available |
|
| ADRs Induced by Drug |
|
|
